Cited by 102Viral Infectious Diseases and Gene Expression in InsectsProtein purification and stabilityTransgenic Plants and Applications

Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells

Mohan·2008·Biotechnology Journal

Abstract

Recombinant glycoprotein therapeutics have proven to be invaluable pharmaceuticals for the treatment of various diseases. Chinese hamster ovary (CHO) cells are widely used in industry for the production of these proteins. Several strategies for engineering CHO cells for improved protein production have been tried with considerable results. The focus has mainly been to increase the specific productivity and to extend the culture longevity by preventing programmed cell death. These CHO cell engineering strategies, particularly those developed in Korea, are reviewed here.

Integrity signals

Registry

OpenAlex · 10.1002/biot.200700249

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chaperones have been employed by many groups as cell engineering tools but have given variable results.

    “They have been employed by many groups as cell engineering tools but have given variable results (Mohan et al., 2008).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Mohan et al., 2008

  • The BiP chaperone gave mixed results, with enhanced or decreased productivity.

    “Similarly, the heavy chain-binding protein (BiP) chaperone gave mixed results, with enhanced or decreased productivity (Mohan et al., 2008).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Mohan et al., 2008

  • Overexpression of ERp57 together with calnexin/calreticulin was able to increase thrombopoietin production in CHO cells.

    “Moreover, overexpression of the endoplasmic-reticulum ERp57 protein, an isoform of PDI, together with calnexin/calreticulin was able to increase thrombopoietin production in CHO cells (Mohan et al., 2008).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Mohan et al., 2008

  • Other studies observed either a negative or no effect on productivity with PDI overexpression.

    “However, other studies observed either a negative or no effect on productivity (Mohan et al., 2008).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Mohan et al., 2008

  • Translational and/or post-translational processes might also be rate-limiting for protein production, because of the lack of correlation between gene copy number and the amount of secreted proteins.

    “It has been suggested that translational and/or post-translational processes might also be rate-limiting for protein production, because of the lack of correlation between gene copy number and the amount of secreted proteins (Wilson et al., 1990;Mohan et al., 2008).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Mohan et al., 2008

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mohan
Venue
Biotechnology Journal
Publisher
Wiley
Published
2008-05
Volume
3
Issue
5
Pages
624-630
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2077304355
Cited by
102
References
41
Citations by year
2025: 2 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 12 · 2012: 9
FWCI
0.67
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
Keywords
CHO cell engineering, therapeutic proteins, specific productivity, culture longevity, programmed cell death, CHO cells, bioprocess optimization
MeSH terms
Animals, Cricetulus, Cricetinae, Recombinant Proteins, Technology Assessment, Biomedical, Protein Engineering, CHO Cells, Genetic Enhancement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review